参考文献/References:
[1]王高强,付兵舰.神经内镜微创术对高血压脑出血患者的血肿清除率及疗效分析[J].中国实用神经疾病杂志,2020,23(10):49-52. [2]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2014)[J].中华神经科杂志,2015,48(6):435-444. [3]郑华煜.王和功.秦智勇/经侧裂-岛叶入路显微手术治疗基底节区高血压脑出血患者的疗效观察及脑血管保护[J].中国医药指南,2015,13(6):58-59. [4]龙晓东,刘之彝,杨与敏.超早期小骨窗微创颅内血肿清除术对高血压脑出血患者生活质量和ET、AVP水平的影响[J].脑与神经疾病杂志,2019,27(3):169-173. [5]韩繁龙,张国来,吴生贵,等.小骨窗与大骨瓣开颅血肿清除术治疗高血压脑出血的疗效分析[J].现代生物医学进展,2016,16(33):6542-6545. [6]周焰.原发性高血压伴脑出血患者测定血清生化指标和生物标志物水平的临床价值[J].标记免疫分析与临床,2015,22(2):101-105. [7]Chen GF,Ping L,Zhou SK,et al.Early prediction of death in acute hypertensive intracerebral hemorrhage[J].Exp Ther Med,2016,11(1):83-88. [8]王为文,张伟,闫忠军,等.小骨窗微创手术治疗急性基底节区高血压脑出血疗效分析[J].临床军医杂志,2017,45(12):1226-1229,1232. [9]齐亮,韩辉,郑金玉,等.神经内镜手术与显微镜手术治疗高血压基底节区脑出血的有效性及安全性研究[J].神经损伤与功能重建,2018,13(1):29-30. [10]刘万荣,魏忠,方有利,等.传统骨瓣开颅血肿清除术与小骨窗入路血肿清除术治疗基底节区高血压脑出血的临床疗效对比观察[J].安徽医药,2017,21(10):1844-1846. [11]翟安林,袁淼,苟志勇,等.经外侧裂入路手术治疗高血压基底节区脑出血后TNF-α的表达研究[J].四川医学,2014,35(3):307-309. [12]杨佳强,张钺,余胜坤.经侧裂-岛叶入路显微手术治疗基底节区高血压性脑出血[J].中国临床研究,2016,29(5):624-626. [13]Gotob S,Hata J,Ninomiya T,et al.Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community[J].Circ J,2014(78):403-409. [14]严亿军.经侧裂-岛叶入路显微外科手术治疗38 例基底节区高血压脑出血的临床疗效[J].临床急诊杂志,2016,17(1):63-65. [15]范广明,张文,毛振立,等.神经内镜微创手术与小骨窗开颅显微手术治疗幕上高血压脑出血的临床效果[J].解放军医药杂志,2017,29(1):90-93.
相似文献/References:
[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,31(05):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,31(05):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,31(05):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,31(05):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Medical Information,2022,35(05):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[7]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,31(05):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[8]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者
轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,31(05):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[9]袁 敏,周袁成.钙离子拮抗剂类降压药的临床应用与不良反应分析[J].医学信息,2018,31(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,31(05):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[10]陈学军,李 敏,张 丹,等.社区一体化分级管理模式对社区老年高血压患者的管理效果[J].医学信息,2018,31(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Medical Information,2018,31(05):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]